Compass Therapeutics, Inc.
CMPX
$3.15
$0.134.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.95M | 112.64M | 126.72M | 135.40M | 146.23M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.25M | 11.51M | 6.03M | 5.74M | 7.32M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 106.20M | 124.15M | 132.75M | 141.14M | 153.55M |
|
|
|||||
| Total Current Assets | 106.20M | 124.15M | 132.75M | 141.14M | 153.55M |
| Net Property, Plant & Equipment | 9.94M | 6.74M | 7.08M | 7.44M | 1.75M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 568.00K | 568.00K | 568.00K | 568.00K | 320.00K |
| Total Assets | 116.70M | 131.45M | 140.40M | 149.15M | 155.61M |
|
|
|||||
| Total Accounts Payable | 2.60M | 1.58M | 2.25M | 960.00K | 1.19M |
| Total Accrued Expenses | 10.99M | 13.21M | 6.29M | 2.92M | 7.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 271.00K | 109.00K | 338.00K | 557.00K | 1.09M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 13.86M | 14.90M | 8.87M | 4.43M | 9.51M |
|
|
|||||
| Total Current Liabilities | 13.86M | 14.90M | 8.87M | 4.43M | 9.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.63M | 6.27M | 6.30M | 6.32M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 23.49M | 21.17M | 15.17M | 10.75M | 9.51M |
|
|
|||||
| Common Stock & APIC | 494.20M | 491.41M | 489.71M | 487.56M | 485.37M |
| Retained Earnings | -401.20M | -381.32M | -364.68M | -349.65M | -339.17M |
| Treasury Stock & Other | 208.00K | 190.00K | 210.00K | 486.00K | -91.00K |
| Total Common Equity | 93.21M | 110.28M | 125.23M | 138.40M | 146.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 93.21M | 110.28M | 125.23M | 138.40M | 146.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 93.21M | 110.28M | 125.23M | 138.40M | 146.10M |
|
|
|||||